Wuhan BIOVIVO Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research, development, manufacturing, sales, and technical services of in vivo imaging systems for both animal and plant research. Dedicated to advancing life science research, BIOVIVO provides high-performance imaging instruments and integrated research solutions. Its proprietary BIOVIVO series of animal and plant in vivo imaging systems integrates fluorescence, bioluminescence, and multispectral imaging technologies, supporting a wide range of applications including oncology, drug discovery, cell tracking, gene expression analysis, plant science, and agricultural biotechnology. Backed by three core technology platforms?plant genetic transformation, cell gene editing, and in vivo imaging?BIOVIVO delivers advanced research instruments, technical services, and customized solutions to universities, research institutes, hospitals, and biopharmaceutical companies worldwide, accelerating innovation in life.

BIOVIVO G Series? plant imaging system is specifically developed by?Wuhan Biovivo Biotechnology to accommodate the physiological morphology of plant growth . This advanced system provides cost-effective solutions for in vivo plant imaging and analysis .
The Biovivo B system empowers researchers to perform real-time monitoring and recording of specific gene and cellular activities, dynamic movements, infectious disease progression, tumor growth and metastasis processes, as well as drug treatment-induced biological phenomena in live animal subjects. With its robust imaging and analytical capabilities, this system is well-suited for diverse application fields ranging from fundamental research to preclinical drug evaluation and screening.